This Deadly Drug Can Also Erase Addiction ‘Virtually Overnight’ | WSJ

Key Concepts

Ibogaine, opioid addiction, withdrawal, Bwiti tradition, psychoactive compound, opioid receptors, pharmacological tolerance, opioid replacement therapy, buprenorphine, methadone, cardiotoxicity, clinical trials, negative pattern interrupter.

Ibogaine: A Radical Treatment for Opioid Addiction

The video explores ibogaine, a powerful psychedelic substance derived from the Tabernanthe iboga shrub, as a potential treatment for opioid addiction. It highlights ibogaine's ability to alleviate withdrawal symptoms and reduce cravings, often described as "miraculous" by users. Despite its potential, ibogaine remains illegal in the US due to safety concerns, particularly its cardiotoxicity.

Discovery and Current Status

Ibogaine's potential for treating opioid addiction was discovered accidentally in 1962 by Howard Lotsof. Today, ibogaine treatment is offered in clinics around the world, particularly in countries like Mexico and Brazil where regulations are less restrictive. In the US, ibogaine is classified as a Schedule I narcotic, hindering formal clinical trials.

Ambio Life Sciences: A Case Study

The video features Ambio Life Sciences in Tijuana, Mexico, a clinic offering medically supervised ibogaine treatments. Kyle Ditommaso, a 35-year-old mechanic with a two-decade-long opioid addiction, is presented as a case study. Kyle had tried multiple rehab stints before turning to ibogaine.

The Ibogaine Treatment Process

1. Ceremony: A short ceremony is held to honor the Bwiti tradition.
2. Monitoring: Patients are connected to a heart monitor and closely supervised by medical staff.
3. The "Trip": Patients experience intense visions, sometimes traumatic, and often vomit during the 10-12 hour treatment. The experience is described as a "lucid dream type state."

The Science of Opioid Addiction and Ibogaine's Potential

Dr. Kenneth Alper explains the science behind opioid addiction:

• Opioid Receptors: Opiates bind to opioid receptors, causing them to become less sensitive (pharmacological tolerance).
• Dependence: Tolerance leads to dependence, requiring larger doses to achieve the same effect.
• Withdrawal: Abrupt cessation of opioid use results in severe withdrawal symptoms (nausea, anxiety, sweating, sleeplessness, muscle pains).

Standard opioid replacement therapies (buprenorphine, methadone) aim to reduce withdrawal symptoms and cravings. However, many find these treatments unsatisfactory, reporting a lack of joy and emotional flatness. Studies suggest that while these treatments reduce harm, they are not very effective at getting people off opioids completely.

Evidence and Efficacy

While formal clinical trials in the US are lacking, observational studies suggest ibogaine's efficacy:

• A 2017 study found that 30% of participants reported never using opioids again after ibogaine treatment.
• Another study reported 75% of patients stayed opioid-free for a year after treatment.

It's crucial to note that ibogaine is not a "magic bullet" but a "powerful negative pattern interrupter" that can help individuals break free from opioid dependence.

Risks and Safety Concerns

The primary risk associated with ibogaine is cardiotoxicity, emphasizing the need for proper screening and medical supervision. "The biggest risk of ibogaine use is death."

Legalization Efforts and Research

Bryan Hubbard led an initiative in Texas to fund clinical research into ibogaine. Texas is allocating millions in state funds to establish a public-private research partnership for the first-ever ibogaine clinical trials in the US.

Cost and Accessibility

Ibogaine treatment remains expensive, ranging from $5,000 to $15,000, making it inaccessible to many.

Kyle's Experience

A month after his ibogaine treatment, Kyle reported that his cravings disappeared immediately, although some withdrawal symptoms lingered. He emphasized the importance of being ready to stop using drugs for the treatment to be effective. "It was definitely worth it because even though it has sucked, it was way, way easier than any other route." "It's not something you can just like go and do when you're gonna be fixed. It doesn't work that way. Like you have to be ready to stop doing drugs for it to work."

Conclusion

Ibogaine offers a potential "fighting chance" for individuals battling opioid addiction, but it is not a miracle cure. It requires careful medical supervision and a commitment to change. The ongoing research in Texas represents a significant step towards evaluating ibogaine's therapeutic potential in a controlled setting.